Novo Nordisk A/S
NOVO-B
Κατάταξη σε μετοχές
#107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Τιμή μετοχής
$39.74
Κεφαλαιοποίηση
$175.38B
Αλλαγή (1 ημέρα)
1.28%
Αλλαγή (1 έτος)
-25.58%
Χώρα
DK
Εμπόριο Novo Nordisk A/S (NOVO-B)
Κατηγορία
Healthcare
Ιστορικό τιμής μετοχής για την Novo Nordisk A/S (NOVO-B)
Υψηλότερη τιμή κλεισίματος: $40.26 στις 2026-10-01
Χαμηλότερη τιμή κλεισίματος: $0.14 στις 1988-03-01
Χαμηλότερη τιμή κλεισίματος: $0.14 στις 1988-03-01
Ιστορικό τιμής μετοχής της Novo Nordisk A/S από 1988 έως 2026
Ετήσια απόδοση τιμής μετοχής
| Έτος | Απόδοση |
|---|---|
| 2026 (TTM) | -4.45% |
| 2025 | -53.02% |
| 2024 | 4.21% |
| 2023 | 52.47% |
| 2022 | 18.08% |
| 2021 | 58.61% |
| 2020 | 21.95% |
| 2019 | 25.17% |
| 2018 | -13.06% |
| 2017 | 48.68% |
| 2016 | -37.84% |
| 2015 | 27.24% |
| 2014 | 25.46% |
| 2013 | 10.41% |
| 2012 | 42.79% |
| 2011 | 5.24% |
| 2010 | 62.58% |
| 2009 | 28.20% |
| 2008 | -21.04% |
| 2007 | 59.27% |
| 2006 | 48.38% |
| 2005 | 2.70% |
| 2004 | 38.02% |
| 2003 | 32.64% |
| 2002 | -24.80% |
| 2001 | 5.84% |
| 2000 | 40.15% |
| 1999 | 7.14% |
| 1998 | -13.94% |
| 1997 | 67.94% |
| 1996 | 44.54% |
| 1995 | 33.16% |
| 1994 | -12.19% |
| 1993 | 12.92% |
| 1992 | 8.32% |
| 1991 | 54.12% |
| 1990 | 3.96% |
| 1989 | 25.86% |
| 1988 | 0.00% |
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Τιμή μετοχής | Μεταβολή 1Έτ% | Χώρα |
|---|---|---|---|
| $1.31K | 61.21% |
US
|
|
| $268.35 | 39.08% |
US
|
|
| $284.58 | 24.44% |
US
|
|
| $147.45 | 68.30% |
US
|
|
| $482.01 | 30.76% |
CH
|
